Vitamin B6 and Magnesium: A Double-Edged Sword
Vitamin B6 and magnesium: A double-edged sword association
An honest look at what science really says
Magnesium never travels alone — really?
Go to any pharmacy or parapharmacy, look for a magnesium supplement: you will find almost no formula without vitamin B6. The marketing message is clear — "B6 helps absorb magnesium" — and it has spread so widely that it is now presented as a given.
But is this really what science says? The answer, after delving into some twenty studies published between 1981 and 2025, is significantly more nuanced — and, in some respects, more concerning than the labels suggest.
What exactly is B6?
Before getting to the heart of the matter, a biochemical point that changes everything.
"Vitamin B6" is not a single molecule: it is a group of six vitamers — pyridoxine (PN), pyridoxal (PL), pyridoxamine (PM) and their phosphorylated forms. Among them, only one is biologically active: pyridoxal-5-phosphate (PLP or P5P). It is in this form that B6 functions as a coenzyme in over 150 enzymatic reactions in the human body, including the synthesis of neurotransmitters (GABA, serotonin, dopamine).
The problem? Pyridoxine — the form used in 90% of dietary supplements — is the inactive form. To become PLP, it must be phosphorylated via pyridoxine kinase (with magnesium and ATP as cofactors), then oxidized via PNPO (an enzyme that requires vitamin B2). This process is competitive: taken in excess, pyridoxine inhibits the enzymes that depend on active PLP. In other words, supplementing with pyridoxine can paradoxically create symptoms of B6 deficiency.
Why are they associated in the first place?
The hypothesis of a link between magnesium and B6 is old. Several mechanisms have been proposed:
1. B6 would facilitate the cellular entry of magnesium. A 1981 study (Abraham et al.) showed that administering 100 mg of B6 twice daily for one month doubled red blood cell magnesium levels in premenopausal women. The authors concluded that B6 plays a fundamental role in the active transport of minerals across cell membranes.
2. B6 forms complexes with magnesium. In vitro studies (Boylan & Spallholz, 1990) have shown that pyridoxal phosphate (PLP) — and not pyridoxine — can form a coordinated complex with magnesium, likely facilitating its intracellular transport.
3. The two nutrients share metabolic pathways. A magnesium deficiency alters B6 metabolism (Planells et al., 1997), and conversely, B6 is necessary for the activation of certain magnesium-dependent enzymes. Their biochemical interdependence is real.
These arguments were enough for the supplement industry to massively adopt the association — often with very high doses of pyridoxine.
What clinical trials really say
Two major series of studies deserve honest examination.
The Pouteau et al. 2018 trial (PLoS ONE)
This is the most cited study to defend the superiority of the Mg+B6 combo. It is a single-blind randomized trial on 264 stressed adults with mild hypomagnesemia, comparing magnesium alone (300 mg/day) versus magnesium + B6 (300 mg + 30 mg/day of pyridoxine).
Overall result: no statistically significant difference between the two groups in stress reduction at 8 weeks (p > 0.05).
Important nuance: in the subgroup of individuals with severe to extremely severe stress (approximately 60% of the sample), the Mg+B6 group showed a 24% greater improvement. An interesting result — but derived from a post hoc subgroup analysis, which limits its statistical robustness.
The secondary study by Noah et al. (2020) confirms that B6 does not significantly increase erythrocyte magnesium levels beyond the effect of magnesium alone.
The Lee & Leklem, 1984 study
Less known but eloquent: a supplementation of 10.4 mg/day of B6 for 48 days had no effect on plasma and erythrocyte magnesium levels in healthy women. Conclusion: at usual doses, B6 does not modify magnesium levels.
The 1986, Eisinger & Dagorn
Only very high doses of B6 (1 g or more per day) seem to increase erythrocyte magnesium. At doses below 1 g/day, no effect on intestinal magnesium absorption. However, at 1 g/day, neurological complications appear... making these doses "unadvisable, even if effective", according to the authors themselves.
The conclusion that emerges: the Mg+B6 association offers a marginal benefit, limited to certain profiles (severe stress, significant hypomagnesemia), and the dose required for B6 to have a real impact on magnesium is precisely the dose at which its toxicity begins.
The big blind spot: B6 neurotoxicity
This is the most underestimated aspect, yet documented since the 1980s.
Peripheral neuropathy: a real risk, at lower doses than commonly believed
Excess vitamin B6 causes neuropathies — primarily sensory, with ataxia, gait disturbances, numbness. What was once associated with megadoses (several grams per day) is now observed at much lower doses.
The EFSA review (2023) set the tolerable upper limit (UL) at 12 mg/day for adults, including pregnant and breastfeeding women. This decision is based on a systematic evaluation of peripheral neuropathies associated with B6 — and cases have been reported even below this threshold.
A Dutch study (Van Hunsel et al., 2018, Drug Safety) analyzed 90 reports of neuropathy linked to B6-containing supplements. Conclusion: causality is plausible, and doses below 50 mg/day cannot be excluded as a cause of neuropathy.
A 2025 Polish case study (Kościńska-Shukla et al., Rheumatology International) goes even further: it describes for the first time symptoms of the central nervous system — and not just peripheral — associated with B6 overload, with spontaneous normalization upon cessation of supplementation. Patients presented with symptoms mimicking rheumatological diseases, revealing a diagnostic "blind spot": few doctors consider B6 levels in the presence of unexplained neuropathy.
The pyridoxine paradox
Ironically, prolonged supplementation with pyridoxine — the dominant inactive form in supplements — can, according to Vrolijk et al. (2017), reduce B6 function by competitively inhibiting PLP-dependent enzymes. In other words: the more pyridoxine you take, the more likely you are to find yourself in a functional state of active B6 deficiency.
The "normal" dose of market supplements is often in the grey area
The best-selling Mg+B6 products typically contain 30 to 50 mg of pyridoxine per capsule. For a daily intake of 200-300 mg of magnesium, this can mean 2 to 3 capsules per day, or 60 to 150 mg of B6 — between 5 and 12 times the EFSA UL. Over months or years, this level of cumulative exposure is concerning.
What if the form of B6 changed everything?
Several sources, including Chambers' review (2023) in Medical & Clinical Research, argue that the problem is not B6 itself, but the form used.
P5P (pyridoxal-5-phosphate), the bioactive form directly usable without hepatic transformation, would be:
- more effective at an equivalent dose to increase intracellular magnesium absorption
- potentially less neurotoxic, as it does not accumulate in inactive form in nervous tissues
This hypothesis is attractive, but human data remains limited. What is certain: premium formulas offering P5P (Pure Encapsulations, Thorne Research, Jarrow Formulas, etc.) are based on more solid biochemistry than standard formulas based on pyridoxine.
What this means in practice
If you take magnesium:
- The absolute priority remains the form of magnesium and its absorption (citrate, malate, glycinate > oxide, carbonate)
- The addition of B6 is not essential for most people
- If you wish to include B6, opt for P5P rather than pyridoxine, at reasonable doses (≤ 10 mg/day)
- Be wary of formulas with 30-50 mg of pyridoxine per capsule
If you experience tingling, numbness, or coordination problems:
- Consider having your serum B6 level measured
- Check all your dietary supplements, not just "magnesium B6" — B6 is hidden in multivitamins, B-complexes, sports supplements, enriched foods
If you have severe stress with confirmed hypomagnesemia:
- Pouteau et al. (2018) data suggest that the Mg+B6 combination may provide an additional benefit in this specific context
- Limited duration (8 weeks in the trial), with monitoring
In summary
| Question | Honest answer |
|---|---|
| Is B6 the "magnesium cofactor"? | No — they are two independent cofactors sharing common pathways |
| Does B6 improve magnesium absorption? | Marginally, especially in P5P form, and only at high doses |
| Is the Mg+B6 combo superior to Mg alone? | Overall no — except for individuals with severe stress + hypomagnesemia |
| Is B6 (pyridoxine) risk-free? | No — documented risk of neuropathy, even at doses < 50 mg/day long-term |
| Which form of B6 to choose? | P5P preferably, at a low dose |
| Should all Mg+B6 products be avoided? | Not necessarily, but check B6 doses and limit duration |
Conclusion
The marketing of the magnesium-vitamin B6 association is based on real biochemistry but has been oversimplified — and the doses adopted by the industry far exceed what studies justify. Vitamin B6 is not just a benign "boost" for magnesium: it is a powerful nutrient, whose excess — especially in the form of inactive pyridoxine — can cause sometimes irreversible neurological damage.
The good news: science now offers informed alternatives. Relying on quality magnesium (organic, bioavailable form), associating it if necessary with P5P at a reasonable dose, and monitoring the overall accumulation of B6 from all sources — this is what recent data suggest.
Sources: compiled Mg ↔ B6 bibliography including Abraham et al. 1981, Lee & Leklem 1984, Eisinger & Dagorn 1986, Boylan & Spallholz 1990, Planells et al. 1997, Van Hunsel et al. 2018, Pouteau et al. 2018, Noah et al. 2020, Yuan et al. 2025 (Brain & Behavior), Kościńska-Shukla et al. 2025 (Rheumatology International), Sun et al. 2025 (Behavioural Neurology), Chambers 2023 (Medical & Clinical Research), EFSA 2015 & 2023.
